Charles Morris

Charles Morris

Director Técnico/Científico/I+D en PRELUDE THERAPEUTICS INCORPORATED .
61 años
Health Technology
Consumer Services

Perfil

Charles Q.
Morris
is currently a Member at The Royal College of Physicians and Chief Medical Officer at Prelude Therapeutics, Inc. starting in 2026.
Former positions include Vice President-Worldwide Clinical Research at Cephalon, Inc., Chief Development Officer & Executive VP at ImmunoGen, Inc. from 2012 to 2016, Chief Medical Officer & Executive Vice President at Allos Therapeutics, Inc. from 2010 to 2012, Chief Medical Officer at Radius Health, Inc. from 2018 to 2020, Vice President-Clinical Development Projects at AstraZeneca Pharmaceuticals LP, Chief Development Officer at Akamis Bio Ltd. from 2016 to 2018, and Chief Medical Officer at Celyad Oncology SA from 2021 to 2023.
Education includes undergraduate studies at the University of Sheffield Medical School.

Cargos activos de Charles Morris

EmpresasCargoInicio
PRELUDE THERAPEUTICS INCORPORATED Director Técnico/Científico/I+D 20/04/2026
Corporate Officer/Principal 09/07/2010

Antiguos cargos conocidos de Charles Morris.

EmpresasCargoFin
LAVA THERAPEUTICS N.V. Director Técnico/Científico/I+D 01/10/2025
CELYAD ONCOLOGY SA Director Técnico/Científico/I+D 01/01/2023
RADIUS HEALTH, INC. Director Técnico/Científico/I+D 15/12/2020
Corporate Officer/Principal 01/09/2018
IMMUNOGEN, INC. Corporate Officer/Principal 02/09/2016
Ver el detalle de la experiencia de Charles Morris.

Formación de Charles Morris.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

64

Relaciones de 1er grado

11

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas11

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services